J Code

NAROPIN is an Anesthetic drug manufactured by Fresenius Kabi and administered via the Injection route of administration. The J Code: J2795 is aligned to the drug NAROPIN.

PHENTOLAMINE MESYLATE is a Cardiology drug manufactured by Tagi Pharma and administered via the Injection route of administration. The J Code: J2760 is aligned to the drug PHENTOLAMINE MESYLATE.

RISPERDAL CONSTA is a Psychiatric drug manufactured by Janssen and administered via the Intramuscular route of administration. The J Code: J2794 is aligned to the drug RISPERDAL CONSTA.

ARCALYST is an Immunology drug manufactured by Regeneron and administered via the Subcutaneous route of administration. The J Code: J2793 is aligned to the drug ARCALYST.

WINRHO SDF is a Hematology drug manufactured by Saol Therapeutics and administered via the Intravenous route of administration. The J Code: J2792 is aligned to the drug WINRHO SDF.

RHOPHYLAC is an Immunology drug manufactured by CSL Behring and administered via the Injection route of administration. The J Code: J2791 is aligned to the drug RHOPHYLAC.

HYPERRHO S-D is an Immunology drug manufactured by Grifols and administered via the Intramuscular route of administration. The J Code: J2790 is aligned to the drug HYPERRHO S-D.

HYPERRHO S-D is a Hematology drug manufactured by Grifols and administered via the Intramuscular route of administration. The J Code: J2788 is aligned to the drug HYPERRHO S-D.

PHOTREXA CROSS-LINKING is an Opthalmic drug manufactured by Glaukos and administered via the Ophthalmic route of administration. The J Code: J2787 is aligned to the drug PHOTREXA CROSS-LINKING.

CINQAIR is an Anti-Eosinophil Asthma drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J2786 is aligned to the drug CINQAIR.

LEXISCAN is an Imaging/Radiopharmaceutical drug manufactured by Astellas Pharma and administered via the Intravenous route of administration. The J Code: J2785 is aligned to the drug LEXISCAN.

ELITEK is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J2783 is aligned to the drug ELITEK.